In last trading session, Adicet Bio Inc (NASDAQ:ACET) saw 0.36 million shares changing hands with its beta currently measuring 1.66. Company’s recent per share price level of $0.63 trading at -$0.04 or -6.71% at ring of the bell on the day assigns it a market valuation of $51.75M. That closing price of ACET’s stock is at a discount of -169.84% from its 52-week high price of $1.70 and is indicating a premium of 28.57% from its 52-week low price of $0.45. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.38 million shares which gives us an average trading volume of 536.66K if we extend that period to 3-months.
For Adicet Bio Inc (ACET), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.33. Splitting up the data highlights that, out of 2 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 2 see the stock as a Buy. 0 analyst(s) advised it as an Underweight.
Adicet Bio Inc (NASDAQ:ACET) trade information
Upright in the red during last session for losing -6.71%, in the last five days ACET remained trading in the red while hitting it’s week-highest on Friday, 06/27/25 when the stock touched $0.63 price level, adding 8.62% to its value on the day. Adicet Bio Inc’s shares saw a change of -57.44% in year-to-date performance and have moved -6.63% in past 5-day. Adicet Bio Inc (NASDAQ:ACET) showed a performance of -4.20% in past 30-days. Number of shares sold short was 2.89 million shares which calculate 5.64 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of 32.5 to the stock, which implies a rise of 98.06% to its current value. Analysts have been projecting 27 as a low price target for the stock while placing it at a high target of 38. It follows that stock’s current price would drop -4185.71% in reaching the projected high whereas dropping to the targeted low would mean a loss of -4185.71% for stock’s current value.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 36.74% during past 5 years. In 2025, company’s earnings growth rate is likely to be around 24.19% while estimates for its earnings growth in next 5 years are of 19.34%.
Adicet Bio Inc (NASDAQ:ACET)’s Major holders
Insiders are in possession of 2.81% of company’s total shares while institution are holding 67.61 percent of that, with stock having share float percentage of 69.57%. Investors also watch the number of corporate investors in a company very closely, which is 67.61% institutions for Adicet Bio Inc that are currently holding shares of the company. ORBIMED ADVISORS LLC is the top institutional holder at ACET for having 11.45 million shares of worth $13.85 million. And as of 2024-06-30, it was holding 12.6303 of the company’s outstanding shares.
The second largest institutional holder is TANG CAPITAL MANAGEMENT LLC, which was holding about 8.22 million shares on 2024-06-30. The number of shares represents firm’s hold over 9.0663 of outstanding shares, having a total worth of $9.94 million.
